Recorded at the AATS annual meeting in Seattle, our hosts are joined by Dr. El-Hamamsy & Dr. Ouzounian to explore the resurgence of the Ross procedure. The discussion covers the evolving evidence base, training requirements, and technical considerations surrounding this increasingly prevalent operation. Dr. El-Hamamsy and Dr. Ouzounian share their own learning curves, views on centralising care, and the importance of surgical volume for patient outcomes. Listeners will also hear about best practices in patient selection, graft support strategies, and the future of Ross—including potential innovations to expand access globally.

In this thought-provoking discussion, our hosts explore the multifaceted world of leadership in cardiac surgery. Joined by Shirin Bemelmans-Lalezari and Volkmar Falk, we delve into how leadership styles evolve, the balance between authority and empathy, and the importance of team dynamics. Learn of the real-life challenges in managing surgical teams and navigating hierarchy. With insights from both clinical and coaching perspectives, this episode offers valuable reflections for anyone considering or currently in a leadership role within cardiothoracic surgery.

We are pleased to announce the first of a new series of upcoming episodes, titled ‘Pulse Check – Key Papers at a Glance’. Our host Can discuss two recent and impactful EJCTS articles on infective endocarditis. Joined by the renowned, Michael Borger and Torsten Doenst, we explore firstly the implications of preoperative septic cerebral embolism for patients undergoing valve surgery. Then followed by an exploration into the use of haemoadsorption therapy, addressing the key issue of controlling inflammation during cardiac surgery for endocarditis.

Listen to gain rapid insight into the associated articles:

Effect of haemoadsorption during cardiac surgery for Staphylococcus aureus endocarditis: a REMOVE trial post hoc analysis

Outcomes following heart valve surgery in patients with infective endocarditis and preoperative septic cerebral embolism: insights from the CAMPAIGN study group'